Sutro Biopharma OverviewSutro Biopharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for STRO.
Quarterly EBIT
-$29.66M
↑ 54.6% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$117.02M
↑ 52.26% YoY
Trailing 12 months ending Mar 31, 2026
Sutro Biopharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for STRO.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026